Characterization and functional interrogation of the SARS-CoV-2 RNA interactome.
Details
Serval ID
serval:BIB_93D18BEE04A2
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Characterization and functional interrogation of the SARS-CoV-2 RNA interactome.
Journal
Cell reports
ISSN
2211-1247 (Electronic)
Publication state
Published
Issued date
26/04/2022
Peer-reviewed
Oui
Volume
39
Number
4
Pages
110744
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the COVID-19 pandemic, which has led to a devastating global health crisis. The emergence of variants that escape neutralizing responses emphasizes the urgent need to deepen our understanding of SARS-CoV-2 biology. Using a comprehensive identification of RNA-binding proteins (RBPs) by mass spectrometry (ChIRP-MS) approach, we identify 107 high-confidence cellular factors that interact with the SARS-CoV-2 genome during infection. By systematically knocking down their expression in human lung epithelial cells, we find that the majority of the identified RBPs are SARS-CoV-2 proviral factors. In particular, we show that HNRNPA2B1, ILF3, QKI, and SFPQ interact with the SARS-CoV-2 genome and promote viral RNA amplification. Our study provides valuable resources for future investigations into the mechanisms of SARS-CoV-2 replication and the identification of host-centered antiviral therapies.
Keywords
COVID-19/genetics, Humans, Pandemics, RNA, Viral/genetics, SARS-CoV-2/genetics, Virus Replication/genetics, CP: Microbiology, SARS-CoV-2 RNA interactome, SARS-CoV-2 infection inhibitors, comprehensive identification of RNA binding proteins by mass spectrometry, ChIRP-MS, host RNA binding proteins, host-dependency factors, severe acute respiratory syndrome coronavirus 2, siRNA screen
Pubmed
Web of science
Open Access
Yes
Create date
11/12/2024 10:17
Last modification date
12/12/2024 10:44